Home > Healthcare & Medical Devices > Anastomosis Devices Market
Anastomosis Devices Market Size is projected to showcase substantial progress between 2023 and 2032. The rising number of people diagnosed with cardiovascular and gastrointestinal disorders across several regions will boost the acceptance of anastomosis devices. The devices are widely used in coronary artery bypass surgeries and will help improve the functioning of the left ventricular system, thus enhancing the patient’s survival rate.
Patients are increasingly inclining toward highly non-invasive surgical procedures that use advanced technologies and devices to alleviate their medical condition and fasten the recovery time. As a result, constant technological improvements are being introduced in trans-catheters and drug-eluting stents, which will drive the adoption of anastomosis devices.
In anastomosis devices market technological developments undertaken by medical device firms will help enhance anastomosis devices in terms of their functioning and durability. For example, in January 2023, Lydus Medical received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its microvascular anastomosis suture deployment system, Vesseal. The system is designed for standardized omnivessel anastomoses, allowing fast, safe, simple, and effective procedures.
The healthcare sector globally has been facing the pinch of inflation that has already taken a toll on other businesses. Based on the Consumer Price Index captured in March 2022, healthcare costs recorded a 2% uptick. Patients feeling the crunch of rising prices have either postponed or canceled their procedures for the time being, which may negatively impact market performance in the near future. With the current situation only expected to get worse, the anastomosis devices industry could face significant consequences during the projection period.
Reusable anastomosis devices will capture a sizeable share of the anastomosis devices market by 2032, as professionals in the healthcare sector are constantly looking for ways to conduct cost-effective yet eco-friendly surgeries. Disposable devices notably increase medical wastage and the risk of contracting fatal infections. Besides, it also becomes expensive for hospitals to make new medical equipment purchases regularly. Since the number of cardiovascular surgeries is increasing every year, the demand for reusable anastomosis devices is likely to be higher than that for disposable ones.
Anastomosis devices may find high application in treating cardiovascular conditions as surgeons are using highly non-invasive techniques to carry out surgical procedures. The use of anastomosis devices can help medical professionals in performing surgeries with high precision. The procedure is capable of creating a durable and safe anastomosis even in the most intricate areas of the heart, which will propel the use of anastomosis devices.
North America anastomosis devices market will expand at a robust rate due to drastic changes taking place in the lifestyle of the population, such as unhealthy food habits and sedentary routines. It has resulted in growing cases of gastrointestinal and cardiovascular diseases. According to the Centre for Disease Control and Prevention (CDC), approximately 805,000 people in the U.S. experience a heart attack each year. The staggering figures will likely accelerate the use of anastomosis devices while carrying out cardiovascular procedures in the country.
Well-known organizations dealing in the production of anastomosis devices across the globe include Vitalitec, B. Braun Melsungen, Medical Devices Business Services, Inc., Ethicon (J&J Surgical Technologies), Novare Surgical Systems, Inc., Synovis Micro Companies Alliance, Getinge, Aesdex, LLC, Medtronic, and LivaNova, among several others.